WELCOME
  • Home
    • About the Haplo SCD Consortium
  • Patients & Families
    • Disease Information >
      • Signs and Symptoms
      • Treatment Options
    • Parent-To-Child (Haplo) Transplant >
      • Haplo Transplant Overview
      • Benefits of Haploidentical Donors
      • Meet a Donor
      • Meet a Patient
      • Trial Eligibility
      • Transplant Facilities Near You >
        • Travel and Housing
    • Video Education
    • Patient Advocacy Groups
    • Resources & External Links
  • Healthcare Professionals
    • Trial Aims and Hypotheses
    • Trial Eligibility
    • Preparative Regimen
    • Clinical Sites
    • Core Services
  • News & Events
  • Contact Us

Prior Trial

<PROTOCOL TITLE>
​PRIOR COLLABORATING SITES
  • New York Medical Center (NYMC): Lead Institution; Administrative, Biostatistical and Financial Cores, Clinical Site, Immunology Core, Pulmonary Function and Vascular Cores
  • Medical College of Wisconsin (MCW): Clinical Site, Cell Processing Core, and Immunology Core
  • Tufts Medical Center: HRQL Core
  • Children's Hospital and Research Center Oakland (CHRCO): Clinical Site
  • University of California San Francisco (UCSF): Donor Chimerism Laboratory Core
  • Washington University: Clinical Site, Cell Processing Core, Neuro-imaging Core
  • University of California Los Angeles (UCLA): Clinical Site
  • Ann and Robert H. Lurie Children's Hospital of Chicago: Clinical Site
  • Patient Advocates: Patient and Family Support

What was it about?
Goals
Protocol link

Picture

  • CLICK HERE TO EDIT​
• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit
• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit

RESULTS​

• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit
• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit

• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit
• Lorem ipsum dolor sit amet
• Consectetur adipiscing elit
Haplo Sickle Cell Disease Consortium
Contact Us       About Us